Australian (ASX) Pharmaceuticals & Biotech Dividend Stocks

UPDATED May 30, 2025

Discover Australian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the ASX and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
VLS
Vita Life Sciences
AU$1.821.1%-19.1%AU$100.4mn/aPE11.4xn/a5.5%
CTE
Cryosite
AU$0.752.0%-29.9%AU$36.6mn/aPE20xn/a2.7%
EZZ
EZZ Life Science Holdings
AU$1.574.0%46.9%AU$73.8mAU$5.00PE8.2xE14.3%2.6%
CSL
CSL
AU$246.990.2%-11.8%AU$119.6bAU$312.92PE27.9xE13.0%1.7%
CUV
Clinuvel Pharmaceuticals
AU$10.781.2%-32.2%AU$539.1mAU$24.63PE13.9xE6.9%0.5%
MVP
Medical Developments International
AU$0.654.8%52.9%AU$73.2mAU$2.31PS1.9xE94.6%0%
ACR
Acrux
AU$0.0230%-71.6%AU$9.4mn/aPS11.7xE106.9%0%
VIT
Vitura Health
AU$0.068-2.9%-16.0%AU$45.0mn/aPE23.1xn/a0%